The Invisible Innovation, Why India Needs a Mandatory R&D Disclosure Standard to Unlock Its Potential

The Invisible Innovation, Why India Needs a Mandatory R&D Disclosure Standard to Unlock Its Potential

In the landscape of modern economics, information is the currency of efficient markets. When information flows freely, capital finds its most productive home, rewarding risk and fueling growth. But when information is obscured, a phenomenon known as “information asymmetry” takes hold, distorting incentives and leading to market failure. This is not an abstract academic concept; it is the precise condition plaguing India’s research and development (R&D) ecosystem. Despite the government’s push for self-reliance and technological prowess, corporate R&D intensity in India has stagnated at a meager 0.23% of GDP, a figure that lags far behind global peers. This is not simply a story of risk-averse Indian companies. It is a story of a broken signaling mechanism. When genuine innovation is invisible to the market, it is systematically undervalued. And when it is undervalued, it is chronically underproduced. To break this cycle, India needs a bold, structural intervention: a mandatory R&D and technology disclosure standard that would shine a light on the invisible engines of corporate value creation.

The foundational logic for such a standard can be traced back to a classic work of economic theory: George Akerlof’s 1970 paper, “The Market for ‘Lemons’.” Akerlof used the used car market to illustrate a profound problem. In that market, the seller knows if the car is a reliable “peach” or a defective “lemon,” but the buyer cannot tell the difference. Fearing they will overpay for a lemon, buyers discount the price they are willing to pay for any car. This drives the sellers of genuine peaches out of the market, leaving only lemons behind. The market, due to a lack of information, collapses into a cesspool of low-quality goods.

The exact same logic applies to corporate innovation today. Companies are the sellers, and their R&D projects are the cars. Some are engaged in genuine, high-risk, high-reward fundamental research—the “peaches.” Others are engaged in low-quality, copycat innovation or purely rent-seeking activities designed to game the system—the “lemons.” The investors, who provide the capital, are the buyers. In the current Indian regulatory environment, they operate in a data-poor fog. They cannot reliably distinguish between a company building a foundational patent portfolio and one simply rebranding an existing technology. Because they cannot tell the difference, they discount the value of all companies. The cost of capital rises for everyone, and the genuine innovators, whose complex projects are hardest to value, are penalized the most. Over time, the incentive to invest in deep, risky, transformative R&D erodes. The invisible lemons drive the visible peaches out of the market.

The consequences of this information failure are stark. India’s corporate R&D intensity is a fraction of that in leading economies. Worse, in the absence of structured disclosure, there is no mechanism to systematically weed out the low-quality projects. Capital that should be flowing to the most promising scientific bets is instead being frittered away on duplicative efforts or, worse, captured by firms that excel at projecting an image of innovation without doing the hard work.

The evidence that transparency works is not just theoretical. It is empirical and compelling. A 2018 study by Brown and Martinson published in Management Science found that when the transparency and quality of corporate disclosures improve, R&D intensity rises sharply—by 6% to 12% in OECD economies and 3% to 14% in large cross-country firm samples. Crucially, this effect is most pronounced in equity-dependent, innovation-driven sectors. And it is specific to innovation: capital expenditures on tangible assets like factories and machinery do not see the same rise. This confirms that transparency pushes investment specifically towards the risky, uncertain realm of intangible innovation, rather than just more brick-and-mortar assets.

Even more compelling is the recent evidence from China. A 2023 study published in the China Journal of Accounting Research examined the impact of mandated disclosures on the Shanghai Stock Exchange. The result was a clear spur to higher innovation, particularly in non-state-owned enterprises, high-tech firms, and financially constrained companies—precisely the ones that need efficient capital markets the most. The Chinese experience also revealed a fascinating and important caveat, particularly in sectors like pharmaceuticals. When firms are required to reveal detailed information about their product pipelines, it creates a “Bayesian learning” effect across the entire industry. Companies observe the project quality, technological overlap, and timelines of their competitors. Weaker or cash-constrained firms, upon seeing that their own projects are technologically dominated by a rival’s, make a rational decision to terminate or scale back their efforts. The result is “portfolio purification.” Low-quality, duplicative, or excessively high-risk projects are pruned early. Capital is reallocated towards stronger scientific bets. While this may mean that fewer long-shot projects survive, the overall efficiency of innovation investment improves dramatically. This does not weaken the case for disclosure; it strengthens it. Transparency reallocates innovation effort toward higher-quality opportunities.

India’s R&D ecosystem today operates under the opposite condition. It is a market for invisible lemons. To correct this structural failure, a compelling case can be made for the introduction of a Mandatory R&D and Technology Disclosure Standard, to be incorporated into the Securities and Exchange Board of India’s (SEBI) Listing Obligations and Disclosure Requirements (LODR) Regulations, 2015. This would not be a heavy-handed mandate telling firms how much to spend or what to research. It would be a framework for transparency, requiring listed entities to disclose a structured set of innovation metrics across five critical dimensions:

1. R&D Expenditure: A clear breakdown of capital and revenue expenditure on R&D, with segment-level granularity, allowing investors to separate genuine research spending from general operating costs.

2. Patent Activity: Comprehensive data on patent filings, grants, expirations, and maintenance, providing a clear window into the health and trajectory of a company’s intellectual property pipeline.

3. Technology Workforce Composition: Information on the size and composition of the R&D workforce, signaling the depth of a company’s scientific and engineering capability.

4. Technology Readiness Level (TRL): A standardized, internationally recognized metric for the maturity of major innovation projects, giving investors a clear view of pipeline progress from basic research to market-ready product.

5. Innovation Turnover: The percentage of revenue derived from products introduced in the past three to five years, a powerful measure of a company’s ability to commercialize its R&D.

These kinds of disclosures are routine in more advanced economies, but they are conspicuously absent in India, leaving analysts, investors, and even policymakers to operate in a data-poor environment. A prudent implementation path could involve a voluntary phase for the first two years, allowing companies to build the necessary systems and data quality. After this transition, the disclosure should be made mandatory.

The rationale for adopting this standard rests on five powerful arguments. First, structured disclosure reduces information asymmetry. It enables investors to distinguish between the innovation peaches and the lemons, correcting the market’s tendency to undervalue genuine R&D. Second, better disclosure lowers the cost of capital. When companies are more transparent about their intangible assets, institutional investors gain confidence, share prices become more stable and reflective of true value, and firms can raise money more cheaply to fund further innovation.

Third, transparency strengthens market discipline. When metrics like R&D spend, patent counts, and project maturity are visible to all, firms with weak innovation performance face tangible pressure from shareholders, boards, and competitors to improve. South Korea saw this effect clearly after introducing mandatory intangible disclosures under K-IFRS; companies increased their R&D investment once they knew everyone was watching the numbers. Fourth, disclosure improves innovation productivity and efficiency. As the OECD’s 2021 Intangibles Report confirms, countries with robust innovation reporting get more patents and better commercial outcomes for every unit of currency spent on R&D. Transparency leads to a more efficient allocation of scarce research funds.

Fifth, and most importantly from a policy perspective, mandatory disclosure is a non-distortionary instrument. It does not force companies to spend a single rupee more. It does not cost the government money to implement. It does not favor any particular sector or technology. It allows firms complete freedom in how they choose to innovate. All it does is to ensure that the market has accurate, comparable information. After that, it is investors, not the state, who decide how to reward or penalize firms. It is the purest form of market-based industrial policy.

Markets cannot make lemonade from invisible lemons. By continuing to keep corporate R&D in the shadows, India is systematically undervaluing its most innovative companies and discouraging the very investment it needs to fuel its future growth. A mandatory R&D disclosure standard, implemented through SEBI, is a low-cost, high-impact reform that would shine a light on innovation, empower investors, and create a virtuous cycle where transparency rewards genuine risk-takers. It is time for India to illuminate its R&D landscape. By doing so, it can ensure that the orchard of innovation grows, the juice of commercialization flows, and the nation’s technological potential is finally realized.

Questions and Answers

Q1: What is the “market for lemons” problem, and how does it apply to corporate R&D in India?

A1: The “market for lemons” problem, derived from George Akerlof’s work, describes a situation where buyers cannot distinguish between high-quality (“peaches”) and low-quality (“lemons”) products. In India’s R&D context, investors cannot easily tell which companies are doing genuine, valuable innovation and which are doing low-quality, copycat work. This information asymmetry leads investors to undervalue all companies, penalizing genuine innovators and discouraging overall R&D investment.

Q2: What evidence is provided to show that increased transparency boosts R&D investment?

A2: The article cites several studies. A 2018 study by Brown and Martinson found that improved disclosure transparency increases R&D intensity by 6-12% in OECD economies. Evidence from China (Liu, Ye & Liu, 2023) shows that mandated disclosures on the Shanghai Stock Exchange spurred higher innovation, especially in high-tech and financially constrained firms. South Korea also saw increased R&D after introducing mandatory intangible disclosures under K-IFRS.

Q3: What are the five key dimensions of the proposed Mandatory R&D and Technology Disclosure Standard?

A3: The proposed standard would require listed companies to disclose:

1. R&D Expenditure with segment-level detail.

2. Patent Activity, including filings, grants, and expirations.

3. Technology Workforce Composition (size and skills of R&D staff).

4. Technology Readiness Level (TRL) of major innovation projects.

5. Innovation Turnover (percentage of revenue from new products).

Q4: How would mandatory disclosure lead to “portfolio purification” of innovation projects?

A4: “Portfolio purification” occurs when transparency enables industry-wide learning. By observing competitors’ disclosed project data (quality, timelines, technological overlap), weaker or cash-constrained firms can recognize when their own projects are dominated and make the rational decision to terminate them. This prunes low-quality, duplicative efforts and reallocates capital towards stronger, more promising scientific bets, improving overall innovation efficiency.

Q5: Why is mandatory disclosure described as a “non-distortionary policy instrument”?

A5: It is non-distortionary because it does not force companies to spend a specific amount on R&D, does not favor any particular sector, and does not cost the government money. It does not direct firms on how or what to innovate. Instead, it simply ensures the market has accurate information. After that, it is investors, not the state, who decide how to allocate capital and reward or penalize firms based on their disclosed performance.